Tensha Therapeutics
Latest round
- Series A
Last raised
- Jul 2011
Total raised
- $0.5M
Investors
- 1
About Tensha Therapeutics
Tensha Therapeutics specializes in advancing cancer therapies. The firm is headquartered in Cambridge, US. In January 2016, Roche acquired Tensha Therapeutics for USD 115 mn, emphasizing its commitment to exploring BET inhibitors as a key therapeutic target.Tensha Therapeutics develops innovative healthcare solutions in the oncology sector, particularly in cancer treatment. Their core focus involves the development of BET inhibitors, which are part of a new class of cancer therapies aimed at improving outcomes for patients with various types of cancers.Tensha Therapeutics generates revenue through the direct sales of its cancer therapies to healthcare institutions and providers. Partnerships with larger healthcare organizations and distribution agreements expand its reach in the market. The company plans to expand its product offerings and is targeting new markets to increase its presence in Europe and Asia-Pacific by 2025.
Who invested in Tensha Therapeutics
1 investor across 1 round
See all investors in Tensha Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 28, 2011
Amount
$0.5M
Investors
Questions about Tensha Therapeutics
Who invested in Tensha Therapeutics?
Tensha Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tensha Therapeutics raised?
Tensha Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Tensha Therapeutics last raise money?
Tensha Therapeutics's most recent round on record is a Series A, in Jul 2011.
What does Tensha Therapeutics do?
Tensha Therapeutics specializes in advancing cancer therapies.
Where is Tensha Therapeutics headquartered?
Tensha Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Tensha Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Tensha Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Tensha Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.